Physician
Brookdale Family Care Center, INC.
Brookdale Family Care Center, INC. was paid $8.17M by Medicaid between Jan 2018 and Dec 2024, across 175 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 25% of everything it billed.
33Billing provider infoBROOKDALE FAMILY CARE CENTER, INC.
BROOKLYN, NY 11226
BROOKLYN, NY 11226
33aNPI1962459644assigned 05/28/2006
33bProvider typeFamily Medicine Physician
28Total paid$8.17M
24GClaims493,454
24DCodes billed175
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Family Medicine Physician providers in New York
Rank by total paid#16 of 2,605
Median peer was paid$10K
This provider vs. median809×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,288 | $47K | |
| 2019 | 41,885 | $833K | |
| 2020 | 109,136 | $2.14M | |
| 2021 | 113,151 | $2.08M | |
| 2022 | 92,177 | $1.01M | |
| 2023 | 77,103 | $708K | |
| 2024incomplete | 57,714 | $1.36M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 25% | 24,093 | 21,826 | $2.06M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 11% | 10,364 | 9,729 | $929K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 7.1% | 7,665 | 7,219 | $580K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 7.0% | 6,732 | 6,617 | $573K |
| 92551 | 6.6% | 12,064 | 10,373 | $538K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 6.4% | 6,024 | 5,808 | $523K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 5.1% | 5,557 | 5,450 | $420K |
| 99173 | 3.3% | 10,654 | 9,386 | $273K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 3.0% | 2,897 | 2,673 | $247K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 2.9% | 3,250 | 3,182 | $234K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 2.3% | 1,659 | 1,461 | $186K |
| 99442 | 1.5% | 2,008 | 1,870 | $125K |
163 more codes
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 1.3% | 19,419 | $108K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 1.3% | 1,528 | $108K |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | 1.2% | 1,191 | $99K |
| 99441 | 1.2% | 2,233 | $97K | |
| 90686 | 1.1% | 7,164 | $94K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 7,490 | $69K |
| 1126F | <1% | 24,662 | $59K | |
| 83655 | <1% | 4,221 | $52K | |
| 97802 | <1% | 1,231 | $49K | |
| 99443 | <1% | 744 | $46K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 18,453 | $42K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 6,194 | $42K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 8,345 | $34K |
| 82652 | <1% | 2,494 | $33K | |
| 96127 | <1% | 11,775 | $30K | |
| 80053 | Comprehensive metabolic panel | <1% | 7,643 | $28K |
| 80061 | Lipid panel | <1% | 10,827 | $28K |
| 97803 | <1% | 752 | $26K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 3,027 | $25K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 10,027 | $23K |
| 1159F | <1% | 29,809 | $21K | |
| 90651 | <1% | 1,743 | $21K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 8,194 | $19K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 17,667 | $19K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 171 | $16K |
| 84439 | <1% | 6,930 | $15K | |
| 86803 | <1% | 5,991 | $14K | |
| 90671 | <1% | 369 | $13K | |
| 81001 | <1% | 12,955 | $13K | |
| 96161 | <1% | 983 | $11K | |
| 90620 | <1% | 1,307 | $11K | |
| 90670 | <1% | 1,819 | $11K | |
| 86480 | <1% | 443 | $10K | |
| 90461 | <1% | 1,773 | $10K | |
| 90715 | <1% | 1,057 | $9K | |
| 90633 | <1% | 1,568 | $9K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 2,299 | $9K |
| 90698 | <1% | 1,343 | $8K | |
| 83525 | <1% | 2,250 | $6K | |
| 90734 | <1% | 1,401 | $6K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,955 | $6K |
| 90710 | <1% | 490 | $5K | |
| 90680 | <1% | 836 | $5K | |
| 82728 | <1% | 1,097 | $4K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 294 | $4K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 381 | $4K |
| 86706 | <1% | 1,596 | $4K | |
| 86592 | <1% | 4,154 | $4K | |
| 90660 | <1% | 626 | $4K | |
| 86780 | <1% | 1,593 | $4K | |
| 87340 | <1% | 1,651 | $4K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 207 | $3K |
| 90672 | <1% | 225 | $3K | |
| 90723 | <1% | 507 | $3K | |
| 82607 | <1% | 790 | $3K | |
| 83021 | <1% | 408 | $3K | |
| 90744 | <1% | 928 | $3K | |
| 82746 | <1% | 632 | $2K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 21 | $2K |
| 81003 | <1% | 3,158 | $2K | |
| 88142 | <1% | 399 | $2K | |
| 86580 | <1% | 2,156 | $2K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 255 | $2K |
| 86762 | <1% | 661 | $2K | |
| 90685 | <1% | 160 | $2K | |
| 90696 | <1% | 529 | $2K | |
| 87088 | <1% | 1,124 | $2K | |
| 90750 | <1% | 52 | $2K | |
| 90619 | <1% | 92 | $2K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 14 | $2K |
| 87070 | <1% | 1,524 | $2K | |
| 86765 | <1% | 588 | $2K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 130 | $2K |
| 83550 | <1% | 957 | $2K | |
| 90688 | <1% | 519 | $2K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 69 | $1K |
| 85660 | <1% | 728 | $1K | |
| 81025 | <1% | 3,432 | $1K | |
| 90716 | <1% | 208 | $1K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 12 | $1K |
| 86593 | <1% | 1,512 | $1K | |
| 86787 | <1% | 735 | $1K | |
| 99385 | <1% | 12 | $1K | |
| 82043 | <1% | 854 | $1K | |
| 1160F | <1% | 29,216 | $1K | |
| S9470 | Nutritional counseling, dietitian visit | <1% | 520 | $1K |
| 86735 | <1% | 543 | $1K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 130 | $1K |
| 87338 | <1% | 204 | $1K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 60 | $1K |
| 86140 | <1% | 911 | $993.96 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 432 | $987.34 |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 210 | $963.38 |
| 90707 | <1% | 115 | $932.14 | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 12 | $880.42 |
| 82962 | <1% | 2,531 | $828.18 | |
| 99406 | <1% | 39 | $791.18 | |
| 82947 | <1% | 724 | $743.77 | |
| 83020 | <1% | 284 | $735.23 | |
| 84702 | <1% | 213 | $585.29 | |
| 86696 | <1% | 133 | $560.83 | |
| 86704 | <1% | 251 | $555.32 | |
| 96160 | <1% | 38 | $533.83 | |
| 85610 | <1% | 115 | $415.64 | |
| 82570 | <1% | 293 | $363.02 | |
| 86695 | <1% | 124 | $361.66 | |
| 85730 | <1% | 104 | $302.41 | |
| 90647 | <1% | 72 | $249.90 | |
| 90681 | <1% | 20 | $204.67 | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 136 | $196.33 |
| 80305 | <1% | 68 | $172.63 | |
| 84481 | <1% | 43 | $169.94 | |
| 84156 | <1% | 179 | $168.70 | |
| 84153 | <1% | 31 | $147.12 | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 12 | $125.94 |
| 80076 | <1% | 27 | $117.00 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 112 | $112.87 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 351 | $108.16 |
| 90662 | <1% | 12 | $107.60 | |
| 84999 | <1% | 447 | $87.51 | |
| 84210 | <1% | 14 | $81.99 | |
| 87210 | <1% | 186 | $77.16 | |
| 86003 | <1% | 12 | $54.75 | |
| 86703 | <1% | 32 | $45.51 | |
| 83540 | <1% | 25 | $45.27 | |
| 86038 | <1% | 26 | $36.32 | |
| 90648 | <1% | 23 | $35.70 | |
| 94760 | <1% | 323 | $33.28 | |
| 87400 | <1% | 354 | $29.36 | |
| 82270 | <1% | 53 | $24.32 | |
| 85046 | <1% | 29 | $10.01 | |
| 85008 | <1% | 38 | $8.67 | |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | <1% | 13 | $4.17 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 48 | $0.12 |
| 3051F | <1% | 37 | $0.01 | |
| 1031F | 0% | 637 | $0.00 | |
| 1125F | 0% | 2,731 | $0.00 | |
| 3008F | 0% | 23,377 | $0.00 | |
| 3044F | 0% | 5,671 | $0.00 | |
| 4293F | 0% | 1,136 | $0.00 | |
| 3049F | 0% | 804 | $0.00 | |
| 3079F | 0% | 2,166 | $0.00 | |
| 3074F | 0% | 6,686 | $0.00 | |
| 1036F | 0% | 4,596 | $0.00 | |
| 3061F | 0% | 842 | $0.00 | |
| 3080F | 0% | 557 | $0.00 | |
| 3075F | 0% | 1,301 | $0.00 | |
| 3048F | 0% | 1,706 | $0.00 | |
| 1111F | 0% | 331 | $0.00 | |
| 4010F | 0% | 332 | $0.00 | |
| 1170F | 0% | 644 | $0.00 | |
| 4000F | 0% | 22 | $0.00 | |
| 1035F | 0% | 29 | $0.00 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 13 | $0.00 |
| 3077F | 0% | 1,038 | $0.00 | |
| 3062F | 0% | 2,262 | $0.00 | |
| 3078F | 0% | 6,236 | $0.00 | |
| 3288F | 0% | 614 | $0.00 | |
| 3725F | 0% | 4,163 | $0.00 | |
| 1033F | 0% | 3,184 | $0.00 | |
| 3046F | 0% | 1,320 | $0.00 | |
| 3050F | 0% | 387 | $0.00 | |
| 3210F | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialFIGUEROA, MICHELLE (CFO)
| Provider | Location | Paid |
|---|---|---|
| The Brookdale Hospital Medical Center | Brooklyn, NY | $44.03M |
| The Brookdale Hospital Medical Center | Brooklyn, NY | $15.22M |
| Urban Strategies Brookdale Family Care Center INC | Brooklyn, NY | $2.55M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.